Medico Intercontinental
23.00
+1.58(+7.38%)
Market Cap₹23.19 Cr
PE Ratio-1.97
Company Performance:
1D+7.38%
1M-15.87%
6M-32.35%
1Y-40.68%
5Y-37.92%
View Company Insightsright
More news about Medico Intercontinental
15Feb 26
Medico Intercontinental Reports Strong Q3FY26 Performance with Revenue Growth of 11.60%
Medico Intercontinental Limited delivered strong Q3FY26 results with revenue from operations growing 11.60% to ₹1275.12 lakhs and net profit after tax rising 11.87% to ₹61.15 lakhs compared to the previous year. However, nine-month performance showed challenges with revenue declining 25.52% to ₹3863.74 lakhs and net profit dropping 13.44% to ₹175.95 lakhs, reflecting mixed operational performance during the fiscal year.
 no imag found
26Dec 25
Medico Intercontinental Promoter Increases Stake to 46.40% Through Market Purchase
Medico Intercontinental Limited's Promoter and Managing Director Samir Dilipkumar Shah acquired 1,97,285 equity shares via open market purchase, increasing his shareholding from 44.83% to 46.40%. The transaction was disclosed under SEBI substantial acquisition regulations, with the combined promoter group holding reaching 59.08%.
 no imag found
18Aug 25
Medico Intercontinental Reports Stellar Q1 FY26 Results with 345% Revenue Surge
Medico Intercontinental Limited announced impressive Q1 FY26 results. Standalone total income surged 345% to Rs. 3,011.32 lakhs, with net profit reaching Rs. 483.50 lakhs. Consolidated income rose 263% to Rs. 3,330.41 lakhs, and net profit increased to Rs. 566.84 lakhs. Standalone EPS grew to Rs. 3.19, while consolidated EPS improved to Rs. 3.90. The Board approved these results on August 14, 2025, reflecting strong growth and improved profitability across operations.
 no imag found
14Aug 25
Medico Intercontinental Reports Mixed Q1 Results: Standalone Profit Up, Consolidated Loss
Medico Intercontinental Limited (MIL) announced Q1 FY24 results with contrasting performances. Standalone operations showed improvement with revenue of Rs 1,306.68 crore and net profit of Rs 55.60 crore, up 11.85% year-on-year. However, consolidated figures revealed a net loss of Rs 248.80 crore on revenue of Rs 2,135.49 crore. MIL has adopted the equity method for accounting joint venture investments, replacing proportionate consolidation. The company's AGM is scheduled for September 30 via video conferencing.
 no imag found
Medico Intercontinental
23.00
+1.58
(+7.38%)
1 Year Returns:-40.68%
Industry Peers
Redington
224.51
(+0.17%)
MMTC
65.04
(+0.28%)
BN Agrochem
351.16
(+5.00%)
MSTC
436.10
(+1.41%)
Ravindra Energy
125.27
(-1.85%)
TCC Concept
376.55
(-3.40%)
Creative Newtech
634.35
(-3.15%)
The Yamuna Syndicate
29,489.00
(+0.65%)